High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.
about
HDL particle number and size as predictors of cardiovascular diseaseThe Structure of Dimeric Apolipoprotein A-IV and Its Mechanism of Self-AssociationHigh density lipoprotein: it's not just about lipid transport anymoreQuantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Next stop for HDL: the lung.Serum amyloid A in uremic HDL promotes inflammationA Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass SpectrometryThe effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youthMulti-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.Glycomic analysis of high density lipoprotein shows a highly sialylated particle.Recent advances in proteomic technologies applied to cardiovascular disease.HDL-C: clinical equipoise and vascular endothelial function.HDL-mediated mechanisms of protection in cardiovascular disease.High-density lipoprotein-based drug discovery for treatment of atherosclerosis.High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.
P2860
Q26779287-E60102CF-09C0-44CA-A818-46417669FE17Q27679028-B93DD3EE-DD58-47D4-B28A-9CF000295E92Q34565254-89120C92-620B-4147-89A8-B28716929B5AQ35051225-D5FB10AE-93A2-44FE-A16B-A50D1F237259Q35796385-98610AD3-F39B-4E11-A094-80BF1DCD5874Q35917487-53709924-EB75-427E-9EA8-1099841F0502Q36467197-86E7124B-0A1A-46A8-BB02-E12EE4638474Q37031070-D2C07C8E-1A9F-44EC-B26E-D8E19D251521Q37289377-49A57225-B71A-40DF-959C-AA1F122EB666Q37671683-271E0E20-9155-40AB-B45D-BB6F7F709CC7Q37684531-D5EFB560-F8EF-486A-A540-556196228D84Q38034137-2CDD4F1D-D29C-4BB8-8CD1-797C8A986429Q38087383-BFBA3E73-8DD5-46CA-BC2B-4169D2B214F4Q38220762-42FB8940-49FD-4849-93C7-A8DB7265C4BBQ38506490-2426876A-A172-47C8-B5AD-EA14305F520BQ38762941-1CD529DD-08B5-4970-868D-02DAC9394F71Q42004332-FF702DCC-C38C-4BC1-8AFB-00B374227E90
P2860
High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@ast
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@en
type
label
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@ast
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@en
prefLabel
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@ast
High-Density Lipoprotein Prote ...... y Understanding Functionality.
@en
P2093
P2860
P1476
High-Density Lipoprotein Prote ...... by Understanding Functionality
@en
P2093
Anita Durairaj
Jason L Lu
Scott Gordon
P2860
P2888
P356
10.1007/S12170-009-0069-9
P577
2010-01-01T00:00:00Z
P5875
P6179
1051259698